All stock lists
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
US · Delayed Price · Currency is USD
2.21-0.20 (-8.30%)
Insider Score
––Not scored
ZNTL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ZNTL analyst forecast
ZNTL analyst consensus
No analyst ratings in the last 3 months.
ZNTL 12-month price target
$6.00+182.3% upsideaverage of 2 firms
$10.00High
$2.00Low
Best analysts covering ZNTL
No firm covering ZNTL has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ZNTL analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $10.00 | +141.5% | — | 2026-05-22 | |
| Leerink Partners | — | $2.00 | +51.5% | — | 2025-11-11 | |
| Jefferies | — | $6.00 | +39.4% | — | 2024-06-18 | |
| Morgan Stanley | — | $8.00 | +93.2% | — | 2024-06-18 | |
| Stifel Nicolaus | — | $10.00 | +85.5% | — | 2024-06-18 | |
| Wedbush | — | $4.00 | -29.8% | — | 2024-06-18 | |
| Stifel Nicolaus | — | $32.00 | +157.4% | — | 2024-05-07 | |
| Stifel Nicolaus | — | $70.00 | +145.6% | — | 2022-07-29 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.